Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2025-07-11 pm EDT			5-day change	1st Jan Change
123.28 ^USD	-0.72%		+1.57%	-8.23%

Jul. 08	Agilent Technologies, Inc., Q2 2025 Earnings Call, May 28, 2025
Jul. 08	Evercore ISI Adjusts Price Target on Agilent Technologies to $130 From $125, Maintains In Line Rating	MT

Agilent Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2025

Published on 05/28/2025 at 16:06

Agilent Technologies, Inc. reported earnings results for the second quarter and six months ended April 30, 2025. For the second quarter, the company reported sales was USD 1,668 million compared to USD 1,573 million a year ago. Net income was USD 215 million compared to USD 308 million a year ago. Basic earnings per share from continuing operations was USD 0.75 compared to USD 1.05 a year ago. Diluted earnings per share from continuing operations was USD 0.75 compared to USD 1.05 a year ago.
For the six months, sales was USD 3,349 million compared to USD 3,231 million a year ago. Net income was USD 533 million compared to USD 656 million a year ago. Basic earnings per share from continuing operations was USD 1.87 compared to USD 2.24 a year ago. Diluted earnings per share from continuing operations was USD 1.86 compared to USD 2.23 a year ago.

Latest news about Agilent Technologies, Inc.

Agilent Technologies, Inc., Q2 2025 Earnings Call, May 28, 2025	Jul. 08
Evercore ISI Adjusts Price Target on Agilent Technologies to $130 From $125, Maintains In Line Rating	Jul. 08	MT
Agilent Technologies, Inc.(NYSE:A) added to Russell 1000 Dynamic Index	Jun. 30	CI
Barclays Adjusts Price Target on Agilent Technologies to $125 From $115	Jun. 24	MT
Agilent to Showcase New Products and Innovations At HPLC 2025	Jun. 12	CI
Agilent Technologies, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10:30 AM	Jun. 04
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on January 9, 2023.	Jun. 02	CI
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on May 29, 2024.	Jun. 02	CI
UBS Adjusts Price Target on Agilent Technologies to $130 From $150, Maintains Neutral Rating	May. 29	MT
Nvidia, Salesforce, HP, Chipotle Mexican Grill, MongoDB...	May. 29
Jefferies Adjusts Price Target on Agilent Technologies to $120 From $116, Maintains Hold Rating	May. 29	MT
Evercore ISI Adjusts Price Target on Agilent Technologies to $125 From $132, Maintains In Line Rating	May. 29	MT
TD Cowen Adjusts Price Target on Agilent Technologies to $150 From $135, Maintains Buy Rating	May. 29	MT
JPMorgan Adjusts Price Target on Agilent Technologies to $155 From $160, Maintains Overweight Rating	May. 29	MT
Baird Adjusts Price Target on Agilent Technologies to $141 From $140, Maintains Outperform Rating	May. 29	MT
Leerink Partners Adjusts PT on Agilent Technologies to $135 From $125, Maintains Outperform Rating	May. 29	MT
Life sciences firm Agilent beats quarterly estimates on instrument demand	May. 28	RE
Agilent Fiscal Q2 Earnings, Revenue Rise; Sets Guidance	May. 28	MT
Agilent Technologies, Inc. Provides Earnings Guidance for the Fiscal Third Quarter of 2025	May. 28	CI
Agilent Guides For Q3 EPS of $1.35-$1.37 on Revenue of $1.645-$1.675 Billion, vs FactSet Analyst Consensus of $1.40/Share on Revenue of $1.65 Billion	May. 28	MT
Earnings Flash (A) Agilent Technologies Posts Q2 Revenue $1.67B, vs. FactSet Est of $1.63B	May. 28	MT
Earnings Flash (A) Agilent Technologies Reports Q2 Adjusted EPS $1.31, vs. FactSet Est of $1.26	May. 28	MT
Agilent Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2025	May. 28	CI
Agilent Technologies, Inc. Revises Earnings Guidance for the Fiscal Full Year of 2025	May. 28	CI
Agilent Technologies Appoints August Specht as Chief Technology Officer	May. 28	MT

Chart Agilent Technologies, Inc.

Duration

Period

A: Dynamic Chart

Company Profile

Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (71.8%) and services (28.2%). Net sales are distributed geographically as follows: the United States (34.5%), China and Hong Kong (18.7%) and other (46.8%).

Employees

18,000

Sector

Advanced Medical Equipment & Technology

Calendar

Aug. 18 - Q3 2025 Earnings Release (Projected)

More about the company